ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cystic Fibrosis Treatment Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-18E1299
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Cystic Fibrosis Treatment Market Insights Forecast to 2028
BUY CHAPTERS

Global Cystic Fibrosis Treatment Market Insights, Forecast to 2030

Code: QYRE-Auto-18E1299
Report
December 2024
Pages:129
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Actavis
F.Hoffmann-La Roche
Gilead Sciences
Novartis
Vertex Pharmaceuticals
Abbott
Anthera Pharmaceuticals
Arcturus Therapeutics
Boehringer Ingelheim
Chiesi Farmaceutici
Corbus Pharmaceuticals
Genzyme
Insmed
Johnson & Johnson
Merck Sharp & Dohme
Neovii Biotech
PharmaSwiss
Pharmaxis Limited
Proteostasis Therapeutics
PTC Therapeutics
United Medical
Venus Remedies
Novo Nordisk

Cystic Fibrosis Treatment Market Size

The global Cystic Fibrosis Treatment market is projected to grow from US$ 7508.8 million in 2024 to US$ 13800 million by 2030, at a Compound Annual Growth Rate (CAGR) of 10.7% during the forecast period.

Cystic Fibrosis Treatment Market

Cystic Fibrosis Treatment Market

Cystic fibrosis (CF) is a hereditary disease characterized by abnormalities in the body's salt, aquatic cells, and mucus-producing cells.
Market Analysis and Insights: Global Cystic Fibrosis Treatment Market
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Cystic Fibrosis Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Cystic Fibrosis Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Cystic Fibrosis Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cystic Fibrosis Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Cystic Fibrosis Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Cystic Fibrosis Treatment revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Cystic Fibrosis Treatment Market Report

Report Metric Details
Report Name Cystic Fibrosis Treatment Market
Accounted market size in 2024 US$ 7508.8 million
Forecasted market size in 2030 US$ 13800 million
CAGR 10.7
Base Year 2024
Forecasted years 2025 - 2030
Segment by Type
  • Oral
  • Injection
Segment by Application
  • Hospitals
  • Clinics
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Actavis, F. Hoffmann-La Roche, Gilead Sciences, Novartis, Vertex Pharmaceuticals, Abbott, Anthera Pharmaceuticals, Arcturus Therapeutics, Boehringer Ingelheim, Chiesi Farmaceutici, Corbus Pharmaceuticals, Genzyme, Insmed, Johnson & Johnson, Merck Sharp & Dohme, Neovii Biotech, Novo Nordisk, PharmaSwiss, Pharmaxis, Proteostasis Therapeutics, PTC Therapeutics, United Medical, Venus Remedies
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Cystic Fibrosis Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cystic Fibrosis Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cystic Fibrosis Treatment revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Cystic Fibrosis Treatment Market growing?

Ans: The Cystic Fibrosis Treatment Market witnessing a CAGR of 10.7 during the forecast period 2025-2030.

What is the Cystic Fibrosis Treatment Market size in 2030?

Ans: The Cystic Fibrosis Treatment Market size in 2030 will be US$ 13800 million.

Who are the main players in the Cystic Fibrosis Treatment Market report?

Ans: The main players in the Cystic Fibrosis Treatment Market are Actavis, F. Hoffmann-La Roche, Gilead Sciences, Novartis, Vertex Pharmaceuticals, Abbott, Anthera Pharmaceuticals, Arcturus Therapeutics, Boehringer Ingelheim, Chiesi Farmaceutici, Corbus Pharmaceuticals, Genzyme, Insmed, Johnson & Johnson, Merck Sharp & Dohme, Neovii Biotech, Novo Nordisk, PharmaSwiss, Pharmaxis, Proteostasis Therapeutics, PTC Therapeutics, United Medical, Venus Remedies

What are the Application segmentation covered in the Cystic Fibrosis Treatment Market report?

Ans: The Applications covered in the Cystic Fibrosis Treatment Market report are Hospitals, Clinics, Other

What are the Type segmentation covered in the Cystic Fibrosis Treatment Market report?

Ans: The Types covered in the Cystic Fibrosis Treatment Market report are Oral, Injection

Recommended Reports

Respiratory Disease Therapy

Oncology & Cancer Treatment

Rare & Genetic Disorders

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cystic Fibrosis Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Oral
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Cystic Fibrosis Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cystic Fibrosis Treatment Market Perspective (2019-2030)
2.2 Global Cystic Fibrosis Treatment Growth Trends by Region
2.2.1 Cystic Fibrosis Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cystic Fibrosis Treatment Historic Market Size by Region (2019-2024)
2.2.3 Cystic Fibrosis Treatment Forecasted Market Size by Region (2025-2030)
2.3 Cystic Fibrosis Treatment Market Dynamics
2.3.1 Cystic Fibrosis Treatment Industry Trends
2.3.2 Cystic Fibrosis Treatment Market Drivers
2.3.3 Cystic Fibrosis Treatment Market Challenges
2.3.4 Cystic Fibrosis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Cystic Fibrosis Treatment by Players
3.1.1 Global Cystic Fibrosis Treatment Revenue by Players (2019-2024)
3.1.2 Global Cystic Fibrosis Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Cystic Fibrosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Cystic Fibrosis Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Cystic Fibrosis Treatment Market Concentration Ratio
3.4.1 Global Cystic Fibrosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cystic Fibrosis Treatment Revenue in 2023
3.5 Global Key Players of Cystic Fibrosis Treatment Head office and Area Served
3.6 Global Key Players of Cystic Fibrosis Treatment, Product and Application
3.7 Global Key Players of Cystic Fibrosis Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cystic Fibrosis Treatment Breakdown Data by Type
4.1 Global Cystic Fibrosis Treatment Historic Market Size by Type (2019-2024)
4.2 Global Cystic Fibrosis Treatment Forecasted Market Size by Type (2025-2030)
5 Cystic Fibrosis Treatment Breakdown Data by Application
5.1 Global Cystic Fibrosis Treatment Historic Market Size by Application (2019-2024)
5.2 Global Cystic Fibrosis Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cystic Fibrosis Treatment Market Size (2019-2030)
6.2 North America Cystic Fibrosis Treatment Market Size by Type
6.2.1 North America Cystic Fibrosis Treatment Market Size by Type (2019-2024)
6.2.2 North America Cystic Fibrosis Treatment Market Size by Type (2025-2030)
6.2.3 North America Cystic Fibrosis Treatment Market Share by Type (2019-2030)
6.3 North America Cystic Fibrosis Treatment Market Size by Application
6.3.1 North America Cystic Fibrosis Treatment Market Size by Application (2019-2024)
6.3.2 North America Cystic Fibrosis Treatment Market Size by Application (2025-2030)
6.3.3 North America Cystic Fibrosis Treatment Market Share by Application (2019-2030)
6.4 North America Cystic Fibrosis Treatment Market Size by Country
6.4.1 North America Cystic Fibrosis Treatment Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Cystic Fibrosis Treatment Market Size by Country (2019-2024)
6.4.3 North America Cystic Fibrosis Treatment Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Cystic Fibrosis Treatment Market Size (2019-2030)
7.2 Europe Cystic Fibrosis Treatment Market Size by Type
7.2.1 Europe Cystic Fibrosis Treatment Market Size by Type (2019-2024)
7.2.2 Europe Cystic Fibrosis Treatment Market Size by Type (2025-2030)
7.2.3 Europe Cystic Fibrosis Treatment Market Share by Type (2019-2030)
7.3 Europe Cystic Fibrosis Treatment Market Size by Application
7.3.1 Europe Cystic Fibrosis Treatment Market Size by Application (2019-2024)
7.3.2 Europe Cystic Fibrosis Treatment Market Size by Application (2025-2030)
7.3.3 Europe Cystic Fibrosis Treatment Market Share by Application (2019-2030)
7.4 Europe Cystic Fibrosis Treatment Market Size by Country
7.4.1 Europe Cystic Fibrosis Treatment Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Cystic Fibrosis Treatment Market Size by Country (2019-2024)
7.4.3 Europe Cystic Fibrosis Treatment Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Cystic Fibrosis Treatment Market Size (2019-2030)
8.2 China Cystic Fibrosis Treatment Market Size by Type
8.2.1 China Cystic Fibrosis Treatment Market Size by Type (2019-2024)
8.2.2 China Cystic Fibrosis Treatment Market Size by Type (2025-2030)
8.2.3 China Cystic Fibrosis Treatment Market Share by Type (2019-2030)
8.3 China Cystic Fibrosis Treatment Market Size by Application
8.3.1 China Cystic Fibrosis Treatment Market Size by Application (2019-2024)
8.3.2 China Cystic Fibrosis Treatment Market Size by Application (2025-2030)
8.3.3 China Cystic Fibrosis Treatment Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Cystic Fibrosis Treatment Market Size (2019-2030)
9.2 Asia Cystic Fibrosis Treatment Market Size by Type
9.2.1 Asia Cystic Fibrosis Treatment Market Size by Type (2019-2024)
9.2.2 Asia Cystic Fibrosis Treatment Market Size by Type (2025-2030)
9.2.3 Asia Cystic Fibrosis Treatment Market Share by Type (2019-2030)
9.3 Asia Cystic Fibrosis Treatment Market Size by Application
9.3.1 Asia Cystic Fibrosis Treatment Market Size by Application (2019-2024)
9.3.2 Asia Cystic Fibrosis Treatment Market Size by Application (2025-2030)
9.3.3 Asia Cystic Fibrosis Treatment Market Share by Application (2019-2030)
9.4 Asia Cystic Fibrosis Treatment Market Size by Region
9.4.1 Asia Cystic Fibrosis Treatment Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Cystic Fibrosis Treatment Market Size by Region (2019-2024)
9.4.3 Asia Cystic Fibrosis Treatment Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Cystic Fibrosis Treatment Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Cystic Fibrosis Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Cystic Fibrosis Treatment Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Cystic Fibrosis Treatment Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Cystic Fibrosis Treatment Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Cystic Fibrosis Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Cystic Fibrosis Treatment Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Cystic Fibrosis Treatment Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Cystic Fibrosis Treatment Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Cystic Fibrosis Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Cystic Fibrosis Treatment Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Cystic Fibrosis Treatment Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Cystic Fibrosis Treatment Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Actavis
11.1.1 Actavis Company Details
11.1.2 Actavis Business Overview
11.1.3 Actavis Cystic Fibrosis Treatment Introduction
11.1.4 Actavis Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.1.5 Actavis Recent Developments
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Details
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Cystic Fibrosis Treatment Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.2.5 F. Hoffmann-La Roche Recent Developments
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Details
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Cystic Fibrosis Treatment Introduction
11.3.4 Gilead Sciences Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.3.5 Gilead Sciences Recent Developments
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Cystic Fibrosis Treatment Introduction
11.4.4 Novartis Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.4.5 Novartis Recent Developments
11.5 Vertex Pharmaceuticals
11.5.1 Vertex Pharmaceuticals Company Details
11.5.2 Vertex Pharmaceuticals Business Overview
11.5.3 Vertex Pharmaceuticals Cystic Fibrosis Treatment Introduction
11.5.4 Vertex Pharmaceuticals Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.5.5 Vertex Pharmaceuticals Recent Developments
11.6 Abbott
11.6.1 Abbott Company Details
11.6.2 Abbott Business Overview
11.6.3 Abbott Cystic Fibrosis Treatment Introduction
11.6.4 Abbott Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.6.5 Abbott Recent Developments
11.7 Anthera Pharmaceuticals
11.7.1 Anthera Pharmaceuticals Company Details
11.7.2 Anthera Pharmaceuticals Business Overview
11.7.3 Anthera Pharmaceuticals Cystic Fibrosis Treatment Introduction
11.7.4 Anthera Pharmaceuticals Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.7.5 Anthera Pharmaceuticals Recent Developments
11.8 Arcturus Therapeutics
11.8.1 Arcturus Therapeutics Company Details
11.8.2 Arcturus Therapeutics Business Overview
11.8.3 Arcturus Therapeutics Cystic Fibrosis Treatment Introduction
11.8.4 Arcturus Therapeutics Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.8.5 Arcturus Therapeutics Recent Developments
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Details
11.9.2 Boehringer Ingelheim Business Overview
11.9.3 Boehringer Ingelheim Cystic Fibrosis Treatment Introduction
11.9.4 Boehringer Ingelheim Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.9.5 Boehringer Ingelheim Recent Developments
11.10 Chiesi Farmaceutici
11.10.1 Chiesi Farmaceutici Company Details
11.10.2 Chiesi Farmaceutici Business Overview
11.10.3 Chiesi Farmaceutici Cystic Fibrosis Treatment Introduction
11.10.4 Chiesi Farmaceutici Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.10.5 Chiesi Farmaceutici Recent Developments
11.11 Corbus Pharmaceuticals
11.11.1 Corbus Pharmaceuticals Company Details
11.11.2 Corbus Pharmaceuticals Business Overview
11.11.3 Corbus Pharmaceuticals Cystic Fibrosis Treatment Introduction
11.11.4 Corbus Pharmaceuticals Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.11.5 Corbus Pharmaceuticals Recent Developments
11.12 Genzyme
11.12.1 Genzyme Company Details
11.12.2 Genzyme Business Overview
11.12.3 Genzyme Cystic Fibrosis Treatment Introduction
11.12.4 Genzyme Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.12.5 Genzyme Recent Developments
11.13 Insmed
11.13.1 Insmed Company Details
11.13.2 Insmed Business Overview
11.13.3 Insmed Cystic Fibrosis Treatment Introduction
11.13.4 Insmed Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.13.5 Insmed Recent Developments
11.14 Johnson & Johnson
11.14.1 Johnson & Johnson Company Details
11.14.2 Johnson & Johnson Business Overview
11.14.3 Johnson & Johnson Cystic Fibrosis Treatment Introduction
11.14.4 Johnson & Johnson Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.14.5 Johnson & Johnson Recent Developments
11.15 Merck Sharp & Dohme
11.15.1 Merck Sharp & Dohme Company Details
11.15.2 Merck Sharp & Dohme Business Overview
11.15.3 Merck Sharp & Dohme Cystic Fibrosis Treatment Introduction
11.15.4 Merck Sharp & Dohme Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.15.5 Merck Sharp & Dohme Recent Developments
11.16 Neovii Biotech
11.16.1 Neovii Biotech Company Details
11.16.2 Neovii Biotech Business Overview
11.16.3 Neovii Biotech Cystic Fibrosis Treatment Introduction
11.16.4 Neovii Biotech Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.16.5 Neovii Biotech Recent Developments
11.17 Novo Nordisk
11.17.1 Novo Nordisk Company Details
11.17.2 Novo Nordisk Business Overview
11.17.3 Novo Nordisk Cystic Fibrosis Treatment Introduction
11.17.4 Novo Nordisk Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.17.5 Novo Nordisk Recent Developments
11.18 PharmaSwiss
11.18.1 PharmaSwiss Company Details
11.18.2 PharmaSwiss Business Overview
11.18.3 PharmaSwiss Cystic Fibrosis Treatment Introduction
11.18.4 PharmaSwiss Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.18.5 PharmaSwiss Recent Developments
11.19 Pharmaxis
11.19.1 Pharmaxis Company Details
11.19.2 Pharmaxis Business Overview
11.19.3 Pharmaxis Cystic Fibrosis Treatment Introduction
11.19.4 Pharmaxis Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.19.5 Pharmaxis Recent Developments
11.20 Proteostasis Therapeutics
11.20.1 Proteostasis Therapeutics Company Details
11.20.2 Proteostasis Therapeutics Business Overview
11.20.3 Proteostasis Therapeutics Cystic Fibrosis Treatment Introduction
11.20.4 Proteostasis Therapeutics Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.20.5 Proteostasis Therapeutics Recent Developments
11.21 PTC Therapeutics
11.21.1 PTC Therapeutics Company Details
11.21.2 PTC Therapeutics Business Overview
11.21.3 PTC Therapeutics Cystic Fibrosis Treatment Introduction
11.21.4 PTC Therapeutics Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.21.5 PTC Therapeutics Recent Developments
11.22 United Medical
11.22.1 United Medical Company Details
11.22.2 United Medical Business Overview
11.22.3 United Medical Cystic Fibrosis Treatment Introduction
11.22.4 United Medical Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.22.5 United Medical Recent Developments
11.23 Venus Remedies
11.23.1 Venus Remedies Company Details
11.23.2 Venus Remedies Business Overview
11.23.3 Venus Remedies Cystic Fibrosis Treatment Introduction
11.23.4 Venus Remedies Revenue in Cystic Fibrosis Treatment Business (2019-2024)
11.23.5 Venus Remedies Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Actavis
F.Hoffmann-La Roche
Gilead Sciences
Novartis
Vertex Pharmaceuticals
Abbott
Anthera Pharmaceuticals
Arcturus Therapeutics
Boehringer Ingelheim
Chiesi Farmaceutici
Corbus Pharmaceuticals
Genzyme
Insmed
Johnson & Johnson
Merck Sharp & Dohme
Neovii Biotech
PharmaSwiss
Pharmaxis Limited
Proteostasis Therapeutics
PTC Therapeutics
United Medical
Venus Remedies
Novo Nordisk
List of Tables
    Table 1. Global Cystic Fibrosis Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Oral
    Table 3. Key Players of Injection
    Table 4. Global Cystic Fibrosis Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 5. Global Cystic Fibrosis Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Cystic Fibrosis Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Cystic Fibrosis Treatment Market Share by Region (2019-2024)
    Table 8. Global Cystic Fibrosis Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Cystic Fibrosis Treatment Market Share by Region (2025-2030)
    Table 10. Cystic Fibrosis Treatment Market Trends
    Table 11. Cystic Fibrosis Treatment Market Drivers
    Table 12. Cystic Fibrosis Treatment Market Challenges
    Table 13. Cystic Fibrosis Treatment Market Restraints
    Table 14. Global Cystic Fibrosis Treatment Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Cystic Fibrosis Treatment Revenue Share by Players (2019-2024)
    Table 16. Global Top Cystic Fibrosis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cystic Fibrosis Treatment as of 2023)
    Table 17. Global Cystic Fibrosis Treatment Industry Ranking 2022 VS 2023 VS 2024
    Table 18. Global 5 Largest Players Market Share by Cystic Fibrosis Treatment Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Global Key Players of Cystic Fibrosis Treatment, Headquarters and Area Served
    Table 20. Global Key Players of Cystic Fibrosis Treatment, Product and Application
    Table 21. Global Key Players of Cystic Fibrosis Treatment, Product and Application
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Cystic Fibrosis Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Cystic Fibrosis Treatment Revenue Market Share by Type (2019-2024)
    Table 25. Global Cystic Fibrosis Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Cystic Fibrosis Treatment Revenue Market Share by Type (2025-2030)
    Table 27. Global Cystic Fibrosis Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Cystic Fibrosis Treatment Revenue Share by Application (2019-2024)
    Table 29. Global Cystic Fibrosis Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Cystic Fibrosis Treatment Revenue Share by Application (2025-2030)
    Table 31. North America Cystic Fibrosis Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 32. North America Cystic Fibrosis Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 33. North America Cystic Fibrosis Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 34. North America Cystic Fibrosis Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 35. North America Cystic Fibrosis Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. North America Cystic Fibrosis Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 37. North America Cystic Fibrosis Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Europe Cystic Fibrosis Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 39. Europe Cystic Fibrosis Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 40. Europe Cystic Fibrosis Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 41. Europe Cystic Fibrosis Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 42. Europe Cystic Fibrosis Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Europe Cystic Fibrosis Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Europe Cystic Fibrosis Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 45. China Cystic Fibrosis Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 46. China Cystic Fibrosis Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 47. China Cystic Fibrosis Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 48. China Cystic Fibrosis Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 49. Asia Cystic Fibrosis Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 50. Asia Cystic Fibrosis Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 51. Asia Cystic Fibrosis Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 52. Asia Cystic Fibrosis Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia Cystic Fibrosis Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 54. Asia Cystic Fibrosis Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 55. Asia Cystic Fibrosis Treatment Market Size by Region (2025-2030) & (US$ Million)
    Table 56. Middle East, Africa, and Latin America Cystic Fibrosis Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Cystic Fibrosis Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Cystic Fibrosis Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Cystic Fibrosis Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Cystic Fibrosis Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 61. Middle East, Africa, and Latin America Cystic Fibrosis Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Cystic Fibrosis Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 63. Actavis Company Details
    Table 64. Actavis Business Overview
    Table 65. Actavis Cystic Fibrosis Treatment Product
    Table 66. Actavis Revenue in Cystic Fibrosis Treatment Business (2019-2024) & (US$ Million)
    Table 67. Actavis Recent Developments
    Table 68. F. Hoffmann-La Roche Company Details
    Table 69. F. Hoffmann-La Roche Business Overview
    Table 70. F. Hoffmann-La Roche Cystic Fibrosis Treatment Product
    Table 71. F. Hoffmann-La Roche Revenue in Cystic Fibrosis Treatment Business (2019-2024) & (US$ Million)
    Table 72. F. Hoffmann-La Roche Recent Developments
    Table 73. Gilead Sciences Company Details
    Table 74. Gilead Sciences Business Overview
    Table 75. Gilead Sciences Cystic Fibrosis Treatment Product
    Table 76. Gilead Sciences Revenue in Cystic Fibrosis Treatment Business (2019-2024) & (US$ Million)
    Table 77. Gilead Sciences Recent Developments
    Table 78. Novartis Company Details
    Table 79. Novartis Business Overview
    Table 80. Novartis Cystic Fibrosis Treatment Product
    Table 81. Novartis Revenue in Cystic Fibrosis Treatment Business (2019-2024) & (US$ Million)
    Table 82. Novartis Recent Developments
    Table 83. Vertex Pharmaceuticals Company Details
    Table 84. Vertex Pharmaceuticals Business Overview
    Table 85. Vertex Pharmaceuticals Cystic Fibrosis Treatment Product
    Table 86. Vertex Pharmaceuticals Revenue in Cystic Fibrosis Treatment Business (2019-2024) & (US$ Million)
    Table 87. Vertex Pharmaceuticals Recent Developments
    Table 88. Abbott Company Details
    Table 89. Abbott Business Overview
    Table 90. Abbott Cystic Fibrosis Treatment Product
    Table 91. Abbott Revenue in Cystic Fibrosis Treatment Business (2019-2024) & (US$ Million)
    Table 92. Abbott Recent Developments
    Table 93. Anthera Pharmaceuticals Company Details
    Table 94. Anthera Pharmaceuticals Business Overview
    Table 95. Anthera Pharmaceuticals Cystic Fibrosis Treatment Product
    Table 96. Anthera Pharmaceuticals Revenue in Cystic Fibrosis Treatment Business (2019-2024) & (US$ Million)
    Table 97. Anthera Pharmaceuticals Recent Developments
    Table 98. Arcturus Therapeutics Company Details
    Table 99. Arcturus Therapeutics Business Overview
    Table 100. Arcturus Therapeutics Cystic Fibrosis Treatment Product
    Table 101. Arcturus Therapeutics Revenue in Cystic Fibrosis Treatment Business (2019-2024) & (US$ Million)
    Table 102. Arcturus Therapeutics Recent Developments
    Table 103. Boehringer Ingelheim Company Details
    Table 104. Boehringer Ingelheim Business Overview
    Table 105. Boehringer Ingelheim Cystic Fibrosis Treatment Product
    Table 106. Boehringer Ingelheim Revenue in Cystic Fibrosis Treatment Business (2019-2024) & (US$ Million)
    Table 107. Boehringer Ingelheim Recent Developments
    Table 108. Chiesi Farmaceutici Company Details
    Table 109. Chiesi Farmaceutici Business Overview
    Table 110. Chiesi Farmaceutici Cystic Fibrosis Treatment Product
    Table 111. Chiesi Farmaceutici Revenue in Cystic Fibrosis Treatment Business (2019-2024) & (US$ Million)
    Table 112. Chiesi Farmaceutici Recent Developments
    Table 113. Corbus Pharmaceuticals Company Details
    Table 114. Corbus Pharmaceuticals Business Overview
    Table 115. Corbus Pharmaceuticals Cystic Fibrosis Treatment Product
    Table 116. Corbus Pharmaceuticals Revenue in Cystic Fibrosis Treatment Business (2019-2024) & (US$ Million)
    Table 117. Corbus Pharmaceuticals Recent Developments
    Table 118. Genzyme Company Details
    Table 119. Genzyme Business Overview
    Table 120. Genzyme Cystic Fibrosis Treatment Product
    Table 121. Genzyme Revenue in Cystic Fibrosis Treatment Business (2019-2024) & (US$ Million)
    Table 122. Genzyme Recent Developments
    Table 123. Insmed Company Details
    Table 124. Insmed Business Overview
    Table 125. Insmed Cystic Fibrosis Treatment Product
    Table 126. Insmed Revenue in Cystic Fibrosis Treatment Business (2019-2024) & (US$ Million)
    Table 127. Insmed Recent Developments
    Table 128. Johnson & Johnson Company Details
    Table 129. Johnson & Johnson Business Overview
    Table 130. Johnson & Johnson Cystic Fibrosis Treatment Product
    Table 131. Johnson & Johnson Revenue in Cystic Fibrosis Treatment Business (2019-2024) & (US$ Million)
    Table 132. Johnson & Johnson Recent Developments
    Table 133. Merck Sharp & Dohme Company Details
    Table 134. Merck Sharp & Dohme Business Overview
    Table 135. Merck Sharp & Dohme Cystic Fibrosis Treatment Product
    Table 136. Merck Sharp & Dohme Revenue in Cystic Fibrosis Treatment Business (2019-2024) & (US$ Million)
    Table 137. Merck Sharp & Dohme Recent Developments
    Table 138. Neovii Biotech Company Details
    Table 139. Neovii Biotech Business Overview
    Table 140. Neovii Biotech Cystic Fibrosis Treatment Product
    Table 141. Neovii Biotech Revenue in Cystic Fibrosis Treatment Business (2019-2024) & (US$ Million)
    Table 142. Neovii Biotech Recent Developments
    Table 143. Novo Nordisk Company Details
    Table 144. Novo Nordisk Business Overview
    Table 145. Novo Nordisk Cystic Fibrosis Treatment Product
    Table 146. Novo Nordisk Revenue in Cystic Fibrosis Treatment Business (2019-2024) & (US$ Million)
    Table 147. Novo Nordisk Recent Developments
    Table 148. PharmaSwiss Company Details
    Table 149. PharmaSwiss Business Overview
    Table 150. PharmaSwiss Cystic Fibrosis Treatment Product
    Table 151. PharmaSwiss Revenue in Cystic Fibrosis Treatment Business (2019-2024) & (US$ Million)
    Table 152. PharmaSwiss Recent Developments
    Table 153. Pharmaxis Company Details
    Table 154. Pharmaxis Business Overview
    Table 155. Pharmaxis Cystic Fibrosis Treatment Product
    Table 156. Pharmaxis Revenue in Cystic Fibrosis Treatment Business (2019-2024) & (US$ Million)
    Table 157. Pharmaxis Recent Developments
    Table 158. Proteostasis Therapeutics Company Details
    Table 159. Proteostasis Therapeutics Business Overview
    Table 160. Proteostasis Therapeutics Cystic Fibrosis Treatment Product
    Table 161. Proteostasis Therapeutics Revenue in Cystic Fibrosis Treatment Business (2019-2024) & (US$ Million)
    Table 162. Proteostasis Therapeutics Recent Developments
    Table 163. PTC Therapeutics Company Details
    Table 164. PTC Therapeutics Business Overview
    Table 165. PTC Therapeutics Cystic Fibrosis Treatment Product
    Table 166. PTC Therapeutics Revenue in Cystic Fibrosis Treatment Business (2019-2024) & (US$ Million)
    Table 167. PTC Therapeutics Recent Developments
    Table 168. United Medical Company Details
    Table 169. United Medical Business Overview
    Table 170. United Medical Cystic Fibrosis Treatment Product
    Table 171. United Medical Revenue in Cystic Fibrosis Treatment Business (2019-2024) & (US$ Million)
    Table 172. United Medical Recent Developments
    Table 173. Venus Remedies Company Details
    Table 174. Venus Remedies Business Overview
    Table 175. Venus Remedies Cystic Fibrosis Treatment Product
    Table 176. Venus Remedies Revenue in Cystic Fibrosis Treatment Business (2019-2024) & (US$ Million)
    Table 177. Venus Remedies Recent Developments
    Table 178. Research Programs/Design for This Report
    Table 179. Key Data Information from Secondary Sources
    Table 180. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Cystic Fibrosis Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Cystic Fibrosis Treatment Market Share by Type: 2023 VS 2030
    Figure 3. Oral Features
    Figure 4. Injection Features
    Figure 5. Global Cystic Fibrosis Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 6. Global Cystic Fibrosis Treatment Market Share by Application: 2023 VS 2030
    Figure 7. Hospitals Case Studies
    Figure 8. Clinics Case Studies
    Figure 9. Other Case Studies
    Figure 10. Cystic Fibrosis Treatment Report Years Considered
    Figure 11. Global Cystic Fibrosis Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 12. Global Cystic Fibrosis Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Cystic Fibrosis Treatment Market Share by Region: 2023 VS 2030
    Figure 14. Global Cystic Fibrosis Treatment Market Share by Players in 2023
    Figure 15. Global Top Cystic Fibrosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cystic Fibrosis Treatment as of 2023)
    Figure 16. The Top 10 and 5 Players Market Share by Cystic Fibrosis Treatment Revenue in 2023
    Figure 17. North America Cystic Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 18. North America Cystic Fibrosis Treatment Market Share by Type (2019-2030)
    Figure 19. North America Cystic Fibrosis Treatment Market Share by Application (2019-2030)
    Figure 20. North America Cystic Fibrosis Treatment Market Share by Country (2019-2030)
    Figure 21. United States Cystic Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Canada Cystic Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Cystic Fibrosis Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 24. Europe Cystic Fibrosis Treatment Market Share by Type (2019-2030)
    Figure 25. Europe Cystic Fibrosis Treatment Market Share by Application (2019-2030)
    Figure 26. Europe Cystic Fibrosis Treatment Market Share by Country (2019-2030)
    Figure 27. Germany Cystic Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. France Cystic Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. U.K. Cystic Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Italy Cystic Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Russia Cystic Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Nordic Countries Cystic Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. China Cystic Fibrosis Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 34. China Cystic Fibrosis Treatment Market Share by Type (2019-2030)
    Figure 35. China Cystic Fibrosis Treatment Market Share by Application (2019-2030)
    Figure 36. Asia Cystic Fibrosis Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. Asia Cystic Fibrosis Treatment Market Share by Type (2019-2030)
    Figure 38. Asia Cystic Fibrosis Treatment Market Share by Application (2019-2030)
    Figure 39. Asia Cystic Fibrosis Treatment Market Share by Region (2019-2030)
    Figure 40. Japan Cystic Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. South Korea Cystic Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. China Taiwan Cystic Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Southeast Asia Cystic Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. India Cystic Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Australia Cystic Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Middle East, Africa, and Latin America Cystic Fibrosis Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Cystic Fibrosis Treatment Market Share by Type (2019-2030)
    Figure 48. Middle East, Africa, and Latin America Cystic Fibrosis Treatment Market Share by Application (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Cystic Fibrosis Treatment Market Share by Country (2019-2030)
    Figure 50. Brazil Cystic Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Mexico Cystic Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Turkey Cystic Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Cystic Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Israel Cystic Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. GCC Countries Cystic Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Actavis Revenue Growth Rate in Cystic Fibrosis Treatment Business (2019-2024)
    Figure 57. F. Hoffmann-La Roche Revenue Growth Rate in Cystic Fibrosis Treatment Business (2019-2024)
    Figure 58. Gilead Sciences Revenue Growth Rate in Cystic Fibrosis Treatment Business (2019-2024)
    Figure 59. Novartis Revenue Growth Rate in Cystic Fibrosis Treatment Business (2019-2024)
    Figure 60. Vertex Pharmaceuticals Revenue Growth Rate in Cystic Fibrosis Treatment Business (2019-2024)
    Figure 61. Abbott Revenue Growth Rate in Cystic Fibrosis Treatment Business (2019-2024)
    Figure 62. Anthera Pharmaceuticals Revenue Growth Rate in Cystic Fibrosis Treatment Business (2019-2024)
    Figure 63. Arcturus Therapeutics Revenue Growth Rate in Cystic Fibrosis Treatment Business (2019-2024)
    Figure 64. Boehringer Ingelheim Revenue Growth Rate in Cystic Fibrosis Treatment Business (2019-2024)
    Figure 65. Chiesi Farmaceutici Revenue Growth Rate in Cystic Fibrosis Treatment Business (2019-2024)
    Figure 66. Corbus Pharmaceuticals Revenue Growth Rate in Cystic Fibrosis Treatment Business (2019-2024)
    Figure 67. Genzyme Revenue Growth Rate in Cystic Fibrosis Treatment Business (2019-2024)
    Figure 68. Insmed Revenue Growth Rate in Cystic Fibrosis Treatment Business (2019-2024)
    Figure 69. Johnson & Johnson Revenue Growth Rate in Cystic Fibrosis Treatment Business (2019-2024)
    Figure 70. Merck Sharp & Dohme Revenue Growth Rate in Cystic Fibrosis Treatment Business (2019-2024)
    Figure 71. Neovii Biotech Revenue Growth Rate in Cystic Fibrosis Treatment Business (2019-2024)
    Figure 72. Novo Nordisk Revenue Growth Rate in Cystic Fibrosis Treatment Business (2019-2024)
    Figure 73. PharmaSwiss Revenue Growth Rate in Cystic Fibrosis Treatment Business (2019-2024)
    Figure 74. Pharmaxis Revenue Growth Rate in Cystic Fibrosis Treatment Business (2019-2024)
    Figure 75. Proteostasis Therapeutics Revenue Growth Rate in Cystic Fibrosis Treatment Business (2019-2024)
    Figure 76. PTC Therapeutics Revenue Growth Rate in Cystic Fibrosis Treatment Business (2019-2024)
    Figure 77. United Medical Revenue Growth Rate in Cystic Fibrosis Treatment Business (2019-2024)
    Figure 78. Venus Remedies Revenue Growth Rate in Cystic Fibrosis Treatment Business (2019-2024)
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Cystic Fibrosis CF Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chronic Obstructive Pulmonary Disease COPD Treatment Market Insights Forecast to 2030
Cystic Fibrosis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Treatment of Skin Fibrosis Market Insights Forecast to 2030
Global Cystic Fibrosis Therapeutics Market Research Report 2025
Global Kidney Renal Fibrosis Treatment Market Insights Forecast to 2030
Global Cold Treatment Drug Market Insights Forecast to 2030
Global Cystic Fibrosis Mucoviscoidosis Testing Market Research Report 2024
Cystic Fibrosis Diagnostic Tests Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chronic Respiratory Diseases Treatment Market Insights Forecast to 2030
Global Mucus Clearance Devices for Cystic Fibrosis Market Insights Forecast to 2030
Global Polycystic Ovarian Syndrome PCOS Therapeutics Market Insights Forecast to 2030
Global Solid Tumor Cancer Treatment Market Insights Forecast to 2030
Global Fabry Disease Treatment Market Insights Forecast to 2030
Global Leishmaniasis Treatment Market Insights Forecast to 2030
Global Pseudomonas Aeruginosa Infection Treatment Market Insights Forecast to 2030
Chronic Lung Diseases Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hemoglobinopathy Treatment Market Insights Forecast to 2030
Global Stem Cell Treatments Market Insights Forecast to 2030
Global Male Infertility Treatment Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions